JPRN-UMIN000005626
Completed
未知
Clinical study using positron emission tomography(PET) - PET imaging of Aquapolin-1,4 using TGN020
Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata0 sites100 target enrollmentMay 22, 2011
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- brain tumor,epilepsy,multiple sclerosis, neuromyelitis,Duchenne musclar dystrophy,Alzheimer'
- Sponsor
- Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The person that an examination for 30\-minute imaging is impossible
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
clinical study of positron emission tomography with 3-deoxy-3-[18F]-fluoro-D-glucosehealthy adult volunteer, cancer, epilepsy, Moyamoya disease,Alzheimer's diseaseJPRN-UMIN000008871Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata100
Active, not recruiting
Phase 1
Study of the positron emission tomography (PET) tracer for tau 18F-PI-2620 in individuals with Down syndromeEUCTR2019-004634-41-ESInstitut de Recerca HSCSP80
Completed
Not Applicable
Imaging study using positron emission tomography with AV-45 for dementiaJPRN-UMIN000003608ippon Medical School75
Completed
Not Applicable
Imaging study using positron emission tomography for the effect of nootropics on the athletic performancehealthy adultsJPRN-UMIN000004907ippon Medical School15
Completed
Phase 1
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15